trending Market Intelligence /marketintelligence/en/news-insights/trending/Iomm-StPFq3kc0KV5Qz_wg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Walgreens customer sues company over prescription drug 'clawbacks'

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Walgreens customer sues company over prescription drug 'clawbacks'

A California man is suing Walgreens Boots Alliance Inc., alleging that the retail pharmacy overcharges customers with insurance and has "secret, undisclosed contracts" with benefit managers, according to a lawsuit filed in a district court Aug. 9.

The lawsuit, filed in the U.S. District Court for the Northern District of Illinois, claims that Walgreens uses "secret contracts" with pharmacy benefit managers to charge insured customers more for some generic drugs than they would pay without insurance.

The lawsuit also charges that Walgreens sends "a significant portion" of co-payments it collects from customers to pharmacy benefit managers, a payment known as a "clawback," according to the complaint.

A Walgreens spokesman told S&P Global Market Intelligence in an email that the lawsuit "lacks merit," adding that the company "will vigorously defend against the allegations."

The lawsuit, filed by law firm Hagens Berman Sobol Shapiro LLP, lists David Grabstald, a San Francisco resident and Walgreens customer, as a plaintiff.

The complaint cites a May 2017 prescription drug purchase Grabstald made at the retail pharmacy. The lawsuit alleges that Grabstald paid $21.80 for the prescription using his insurance policy but later found out that he could have paid $10 in cash for the same drug.

"At no point did Walgreens ever advise [Grabstald] that the cash price was less than his insurance price" or disclose its alleged contracts with the pharmacy managers, the complaint states.

The lawsuit does not specify how much Grabstald or others in the class-action suit are seeking in damages.

The complaint comes one day after the same law firm filed a lawsuit making similar allegations against CVS Health Corp., in district court Aug. 7.

In an email to S&P Global, a CVS spokesman said CVS Caremark, the retailers' pharmacy benefits manager, "does not engage in the practice of co-pay clawbacks," adding that the company will defend itself "against these baseless allegations."